CR− | CR+ | p Value | |
A. Medically treated patients | |||
n | 21 | 14 | |
Age (years) | 56 (15) | 48 (15) | 0.14 |
Female sex | 9 (43%) | 6 (43%) | 1.00 |
Weight (kg) | 78 (17) | 84 (24) | 0.45 |
Body surface area (m2) | 1.9 (0.3) | 2.0 (0.3) | 0.45 |
Aortic regurgitation severity | |||
Grade 3+ | 21 | 13 | |
Grade 4+ | 0 | 1 | |
ACE inhibitor | 7 (33%) | 6 (43%) | 0.57 |
Calcium antagonist | 4 (19%) | 5 (36) | 0.27 |
β Blocking agent | 1 (5%) | 2 (14%) | 0.32 |
Digoxin | 3 (14%) | 2 (14%) | 1.00 |
Diuretic | 4 (19%) | 2 (14%) | 0.71 |
Follow up interval | 13 (8) | 15 (7) | 0.63 |
B. Surgically treated patients | |||
n | 13 | 13 | |
Age (years) | 60 (15) | 55 (12) | 0.30 |
Female sex | 4 (31%) | 3 (23%) | 0.66 |
Weight (kg) | 81 (15) | 86 (14) | 0.45 |
Body surface area (m2) | 2.0 (0.2) | 2.1 (0.2) | 0.42 |
Aortic regurgitation severity | |||
Grade 3+ | 6 | 7 | |
Grade 4+ | 7 | 6 | |
Follow up interval | 7 (8) | 5 (7) | 0.59 |
Values are mean (SD) or n (%).
ACE, angiotensin converting enzyme.